Picture this: the dying days of FY16. A 14-member team is working round the clock at a prominent asset reconstruction company (ARC). The goal is to acquire 90% debt of a pharma company that has fallen on hard times. While the control room is set up at the Mumbai head office, the ARC has positioned its troops in six different locations to co-ordinate with various banks. The ARC falls short and is only able to acquire 65%, with certain banks failing to meet the March 31 deadline. Cut to the present. About a year later, the situation is starkly different. Goaded by a policy push, banks offloaded Rs. 20,000 crore of bad loans in the last fortnight of March 2017, among which Rs.5,000 crore belonged to a single bank. Amidst this hectic activity, the ARC business is now attracting the biggest and the best globally. While Wilbur Ross was among the earliest entrants in 2006, JC Flowers has teamed up with Ambit and Lone Star with IL&FS. Even Brookfield has tied up with SBI and Apollo Global is an active player through AION, having partnered with ICICI Venture.
You Owe Us - Part 1
A few ARCs are aggressively bidding for non-performing assets of banks. Can they fix the bad debt problem or are they throwing good money after bad?
Summer wine and salad
Kishore Singh - January 19, 2015
The million-dollar question: Is investing a game of luck or skill?
Shankar Sharma - May 04, 2021
Every crisis is an opportunity, if you are on the right side of equities
Samir Arora - May 04, 2021
Viraj Mehta trusts the toughness and bounce of a company that has seen many trials
Viraj Mehta - May 04, 2021
Safir Anand spots a mid-sized company with the right chemistry and catalytic circumstances
Safir Anand - May 07, 2021